Texas Permanent School Fund Bristol Myers Squibb CO Transaction History

Texas Permanent School Fund

$10.3 Billion
Q1 2025

A detailed history of Texas Permanent School Fund transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Texas Permanent School Fund holds 234,217 shares of BMY stock, worth $10.9 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

234,217

Holding current value

$10.9 Million

% of portfolio

0.14%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$53.9 - $63.11 $12.6 Million - $14.8 Million	234,217 New	234,217 $14.3 Million
Q2 2024 Aug 07, 2024	SELL	$40.25 - $52.99 $3.39 Million - $4.47 Million	-84,324 Reduced 20.05%	336,279 $14 Million
Q1 2024 May 03, 2024	BUY	$47.98 - $54.4 $23,462 - $26,601	489 Added 0.12%	420,603 $22.8 Million
Q4 2023 Feb 08, 2024	SELL	$48.48 - $57.85 $559,701 - $667,878	-11,545 Reduced 2.67%	420,114 $21.6 Million
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $513,426 - $574,090	-8,869 Reduced 2.01%	431,659 $25.1 Million
Q2 2023 Aug 07, 2023	SELL	$63.71 - $70.74 $174,565 - $193,827	-2,740 Reduced 0.62%	440,528 $28.2 Million
Q1 2023 May 01, 2023	BUY	$65.71 - $74.53 $9.28 Million - $10.5 Million	141,183 Added 46.74%	443,268 $30.7 Million
Q4 2022 Feb 07, 2023	SELL	$68.48 - $81.09 $2,739 - $3,243	-40 Reduced 0.01%	302,085 $21.7 Million
Q3 2022 Oct 25, 2022	BUY	$0.13 - $76.84 $2,717 - $1.61 Million	20,907 Added 7.43%	302,125 $21.5 Million
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $109,583 - $120,689	-1,509 Reduced 0.53%	281,218 $21.7 Million
Q1 2022 May 06, 2022	SELL	$61.48 - $73.72 $1.41 Million - $1.69 Million	-22,981 Reduced 7.52%	282,727 $20.6 Million
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $2.01 Million - $2.35 Million	-37,568 Reduced 10.94%	305,708 $19.1 Million
Q3 2021 Oct 28, 2021	SELL	$59.17 - $69.31 $1.65 Million - $1.93 Million	-27,844 Reduced 7.5%	343,276 $20.3 Million
Q2 2021 Jul 27, 2021	SELL	$61.91 - $67.42 $185,606 - $202,125	-2,998 Reduced 0.8%	371,120 $24.8 Million
Q1 2021 May 03, 2021	SELL	$59.34 - $66.74 $1.44 Million - $1.62 Million	-24,308 Reduced 6.1%	374,118 $23.6 Million
Q4 2020 Feb 04, 2021	SELL	$57.74 - $65.43 $1.46 Million - $1.66 Million	-25,322 Reduced 5.98%	398,426 $24.7 Million
Q3 2020 Nov 06, 2020	BUY	$57.43 - $63.64 $1.44 Million - $1.59 Million	25,031 Added 6.28%	423,748 $25.5 Million
Q2 2020 Aug 04, 2020	SELL	$54.82 - $64.09 $1.51 Million - $1.77 Million	-27,632 Reduced 6.48%	398,717 $23.4 Million
Q1 2020 Apr 27, 2020	BUY	$46.4 - $67.43 $536,012 - $778,951	11,552 Added 2.78%	426,349 $23.8 Million
Q4 2019 Feb 03, 2020	BUY	$49.21 - $64.19 $5.42 Million - $7.07 Million	110,097 Added 36.13%	414,797 $26.6 Million
Q3 2019 Oct 31, 2019	SELL	$42.77 - $50.71 $459,777 - $545,132	-10,750 Reduced 3.41%	304,700 $15.5 Million
Q2 2019 Aug 09, 2019	SELL	$44.62 - $49.34 $97,137 - $107,413	-2,177 Reduced 0.69%	315,450 $14.3 Million
Q1 2019 May 02, 2019	SELL	$45.12 - $53.8 $481,340 - $573,938	-10,668 Reduced 3.25%	317,627 $15.2 Million
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $1.85 Million - $2.41 Million	-38,042 Reduced 10.38%	328,295 $17.1 Million
Q3 2018 Oct 22, 2018	SELL	$55.19 - $62.25 $1.8 Million - $2.03 Million	-32,531 Reduced 8.16%	366,337 $22.7 Million
Q2 2018 Jul 23, 2018	SELL	$50.53 - $62.98 $1.16 Million - $1.45 Million	-22,957 Reduced 5.44%	398,868 $22.1 Million
Q1 2018 Apr 20, 2018	SELL	$59.92 - $68.98 $1.5 Million - $1.72 Million	-24,978 Reduced 5.59%	421,825 $26.7 Million
Q4 2017 Jan 23, 2018	SELL	$59.94 - $65.35 $459,739 - $501,234	-7,670 Reduced 1.69%	446,803 $27.4 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $25.1 Million - $29 Million	454,473	454,473 $29 Million

Others Institutions Holding BMY

# of Institutions

2,801

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.4B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.

Account

Texas Permanent School Fund Bristol Myers Squibb CO Transaction History